Medtronic Terminate AF Study (NCT03546374)
Irrigated Radio Frequency Ablation to Terminate Non-Paroxysmal Atrial Fibrillation (Terminate AF Study)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices for the treatment of non-paroxysmal atrial fibrillation (AF).
Who can join: Review the eligibility criteria below.
Location: Stanford Hospitals and Clinic — Palo Alto, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (15 Sites)
- Stanford Hospitals and Clinic — Palo Alto, California
- Adventist Health St. Helena — St. Helena, California
- Hartford Healthcare — Hartford, Connecticut
- St Vincent Heart Center of Indiana — Indianapolis, Indiana
- Massachusetts General Hospital — Boston, Massachusetts
- Corewell Health — Grand Rapids, Michigan
- Washington University School of Medicine — St Louis, Missouri
- ProMedica Toledo — Toledo, Ohio
- Allegheny General Hospital — Pittsburgh, Pennsylvania
- Lankenau Medical Center — Wynnewood, Pennsylvania
- Intermountain Medical Center — Murray, Utah
- Sentara Norfolk General Hospital — Norfolk, Virginia
- Virginia Mason Heart Institute — Seattle, Washington
- Swedish Medical Center — Seattle, Washington
- St. Joseph Medical Center — Tacoma, Washington
📞 Contact the Study Coordinator
Phone: (763) 526-2032
Email: stephanie.yong@medtronic.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Persistent Atrial Fibrillation
- Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias — Jonesboro, Arkansas
- Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation — Birmingham, Alabama
- SPHERE Per-AF Post-Approval Study — Birmingham, Alabama
- Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study — Ottawa, Ontario
- STOP Persistent AF PAS — Hartford, Connecticut
- REPRESENT-PF Registry — New York, New York
Explore by condition: All Persistent Atrial Fibrillation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.